Hypertension: Management of Uncontrolled Hypertension

Why is this important?

The prevalence of hypertension is high, with the risk rising as people age.1 The risk from elevated blood pressure is significant and is a leading cause of preventable death due to cardiovascular disease.  Many people are unaware that they have hypertension and even among those who do, less than half are treated to the recommended target levels.1 The prevalence of resistant hypertension is difficult to assess due to medication non-adherence and pseudo-resistance but may lie between 7% to 28% of the population.2,3 A systematic, team-based approach to managing patients with uncontrolled hypertension in your practice will improve patient outcomes and clinician satisfaction.4

How will these tools help?

  • The risk of cardiovascular disease (CVD) increases in a log-linear fashion beginning from SBP levels of 115 mm Hg and DBP levels of 75 mm Hg. Every 20 mm Hg rise in SBP or 10 mm Hg rise in DBP is associated with a doubling in the risk of death from stroke, heart disease or other vascular disease.
  • Effective blood pressure management has been shown to decrease the incidence of stroke, heart attack, and heart failure.5
  • Hypertension was the leading cause of death and disability worldwide in 2010.  In the US it is 2nd only to tobacco use as a preventable cause of death for any reason.
  • Careful attention must be made to identify pseudo-resistance and non-adherence to prescribed medication regimens.
  • Interfering substances and secondary hypertension are rare causes of resistant hypertension but their influence must be considered and appropriately evaluated.
  • Strategies for the management of resistant hypertension are well defined.

Target Audience

Target Audience

  • Physicians

  • Physician Assistants

  • Nurse Practitioners

  • Registered Nurses

  • Medical Assistants

  • Practice Managers

Learning Objectives

Learning Objectives

  • List common reasons for patients to have uncontrolled hypertension after initial therapy is applied 
  • Identify options for escalating therapy in patients with uncontrolled hypertension on one or two drugs
  • Connect clinicians, patients and families to resources to improve blood pressure control
  • Define resistant hypertension and the optimal methods for treatment
Course summary
Available credit: 
  • 20.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
  • 20.00 ABIM MOC
  • 20.00 ABMS MOC
Course opens: 
08/01/2018
Course expires: 
07/31/2021
Cost:
$0.00
Parent activity set: 
Rating: 
0

Practice Advisor Content Manager

Jillian Schneider, MHA

Manager Practice Support, American College of Physicians

Contributors

Beverly Johnson, BSN

President and Chief Executive Officer

Institute for Patient and Family Centered Care

Mary Minniti, CPHQ

Senior Policy and Programs Specialist

Institute for Patient and Family Centered Care

Cynthia (Daisy) Smith, MD, FACP

Vice President, Clinical Programs

American College of Physicians

Lawrence Ward, MD, MPH, FACP

Executive Vice Chairman of Medicine

Thomas Jefferson University Hospital

Staff Editors

Monica Lizarraga, MPH

Grants Administrator

Disha Patel

Practice Support Coordinator

Cheryl Rusten, MPA

Programs and Grants Manager

Margo Williams, MHA

Senior Associate, Medical Practice

Lawrence D. Ward, MD, MPH, FACP; Professor of Medicine, Executive Vice Chairman of Medicine, Thomas Jefferson University was a major contributor to this module.

Available Credit

  • 20.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
  • 20.00 ABIM MOC
  • 20.00 ABMS MOC

Accreditation Period

Course opens: 
08/01/2018
Course expires: 
07/31/2021

Price

Cost:
$0.00
Please login or register to take this course.